Table 1.

Comparison of clinical, laboratory and radiographic data between patients with AS with and without spinal fusion. Values are mean ± standard deviation, unless indicated otherwise.

CharacteristicWith Spinal Fusion, n = 60Without Spinal Fusion, n = 60p
Men, %85.076.70.354
Age, yrs41.6 ± 12.629.7 ± 8.3< 0.01*
Age at onset, yrs26.8 ± 11.323.4 ± 7.00.115
Disease duration, yrs14.8 ± 8.56.0 ± 5.9< 0.001*
Enthesitis, %43.331.70.258
Uveitis, %13.310.00.777
Peripheral arthritis, %60.066.70.570
HLA-B27, %96.786.70.095
NSAID, %76.7700.536
Sulfasalazine, %43.3400.853
BASRI-spine9.5 ± 3.03.0 ± 1.2< 0.001*
mSASSS36.2 ± 23.20.8 ± 2.7< 0.001*
BASDAI4.5 ± 2.14.7 ± 2.10.791
BASFI4.1 ± 2.52.6 ± 2.50.001*
BASMI6.0 ± 1.82.0 ± 1.8< 0.001*
BAS-G5.9 ± 2.85.7 ± 2.70.625
BMP-298.0 ± 188.586.6 ± 136.5< 0.001*
BMP-4133.6 ± 129.4125.2 ± 446.9< 0.001*
BMP-751.2 ± 96.036.7 ± 64.20.005*
ESR, mm/h31.8 ± 25.323.0 ± 21.00.041*
CRP, mg/dl2.2 ± 2.11.5 ± 1.60.027*
  • * Statistically significant. p values calculated by Mann-Whitney U test, except sex, enthesitis, uveitis, peripheral arthritis, NSAID, and sulfasalazine by chi-square test, and HLA-B27 by Fisher exact test. See text for definitions.